Key result
Novel LC-MS/MS assay rapidly measures ivabradine and N-desmethyl ivabradine in human plasma for pharmacokinetic studies.
Why the study?
A new simple, rapid, sensitive, and simultaneous LC-MS/MS assay method for determining Ivabradine and its active metabolite in human plasma was needed for pharmacokinetic studies.
A new, rapid, and sensitive LC-MS/MS method was successfully developed and validated for the simultaneous measurement of ivabradine and its active metabolite in human plasma for pharmacokinetic studies.
Answers are grounded in this paper and cite their sources.
Enables plasma quantification of ivabradine and metabolite for pharmacokinetic studies; leaves open clinical utility pending patient validation.
The method was new simple, rapid, sensitive and simultaneous liquid chromatography/tandem mass spectrometry assay method for the determination of Ivabradine and N-Desmethyl Ivabradine in human plasma using Ivabradine-d 6 and N-Desmethyl Ivabradine-d 6 as internal standards (IS).Analyte and the internal standards were extracted from the human plasma via Solid phase extraction (SPE) using Strata TM X 33µM polymeric sorbent cartridges (1cc/30mg).The chromatographic separation was achieved on a Kromasil 100-5 C 18 , 100 x 4.6 mm, 5 µm columns by using a gradient programme at a flow rate of 0.60 mL/min with a total runtime of 3.0 min and the elution was monitored by multiple reaction monitoring modes using electropspray ionization.The calibration curve obtained was linear (r 2 0.99) over the concentration range of 0.20-201 ng/mL for Ivabradine and 0.10-15.14for N-Desmethyl Ivabradine.Method validation was performed as per FDA guidelines and the results met the within the acceptable limits.The proposed method was found to be applicable to pharmacokinetic studies.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied Healthy volunteers (n=6). Ivabradine was evaluated on Pharmacokinetic parameters (Cmax, tmax, AUC, t1/2). A novel, simple, and rapid LC-MS/MS method was successfully developed and validated for the simultaneous determination of ivabradine and N-desmethyl ivabradine in human plasma, and applied to a pharmacokinetic study in healthy volunteers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: